Tag: PreveCeutical Medical Inc.
September 3, 2019
PreveCeutical Reaches Milestone in Research Program for Development of Non-Addictive Analgesics
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has recently reached a significant... August 6, 2019
PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property
PreveCeutical Medical Inc. (CSE: PREV) grants Asterion option to purchase up to a 51% Interest in Sol-Gel Intellectual Property July 9, 2019
PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System June 21, 2019
PreveCeutical Announces Appointment of New Directors
PreveCeutical Medical Inc. (CSE:PREV), is pleased to announce the appointments of Keith Anderson and Mark Lotz to the board of... June 17, 2019
PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide positive results from... June 3, 2019
PreveCeutical Secures $300,000 Loan and Resignation of a Director
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)(the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount... May 21, 2019